A Reversal for Medidata Solutions Incorporated (NASDAQ:MDSO) Is Not Near. The Stock Has Rise in Shorts

February 15, 2018 - By Adrian Mccoy

 A Reversal for Medidata Solutions Incorporated (NASDAQ:MDSO) Is Not Near. The Stock Has Rise in Shorts

Investors sentiment increased to 1.23 in 2017 Q3. Its up 0.06, from 1.17 in 2017Q2. It increased, as 38 investors sold Medidata Solutions, Inc. shares while 60 reduced holdings. 33 funds opened positions while 88 raised stakes. 59.30 million shares or 4.96% more from 56.50 million shares in 2017Q2 were reported.
Employees Retirement Of Texas holds 0.02% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 24,000 shares. Metropolitan Life Ins New York accumulated 182,210 shares. Thrivent Financial For Lutherans has 12,520 shares for 0% of their portfolio. Massachusetts-based De Burlo Grp Incorporated has invested 0.68% in Medidata Solutions, Inc. (NASDAQ:MDSO). Fifth Third Bank reported 600 shares stake. Texas Permanent School Fund owns 0.04% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 42,711 shares. Renaissance Group Incorporated Ltd Liability owns 5,322 shares. Manufacturers Life Company The holds 0.01% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 126,722 shares. Parametric Portfolio Assocs Limited Liability Co invested in 95,665 shares or 0.01% of the stock. Northern Tru has invested 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Ny State Common Retirement Fund stated it has 0.1% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Pub Employees Retirement System Of Ohio reported 106,639 shares. The New York-based Citigroup has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). California State Teachers Retirement Sys has invested 0.02% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Barclays Plc stated it has 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO).

Since August 15, 2017, it had 0 insider purchases, and 3 sales for $474,820 activity. On Friday, January 19 the insider Bergmann Rouven sold $132,920.

The stock of Medidata Solutions Incorporated (NASDAQ:MDSO) registered an increase of 11.09% in short interest. MDSO’s total short interest was 6.11M shares in February as published by FINRA. Its up 11.09% from 5.50 million shares, reported previously. With 555,500 shares average volume, it will take short sellers 11 days to cover their MDSO’s short positions. The short interest to Medidata Solutions Incorporated’s float is 11.44%.

The stock increased 4.75% or $3.02 during the last trading session, reaching $66.59. About 625,472 shares traded or 12.04% up from the average. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 68.37% since February 15, 2017 and is uptrending. It has outperformed by 51.67% the S&P500.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $3.90 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 89.99 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 14 have Buy rating, 0 Sell and 3 Hold. Therefore 82% are positive. Medidata Solutions Inc. had 43 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Friday, October 27 by Wells Fargo. The rating was downgraded by Wells Fargo on Thursday, July 21 to “Market Perform”. Piper Jaffray maintained the stock with “Buy” rating in Thursday, February 8 report. The rating was maintained by SunTrust with “Buy” on Friday, October 27. Needham maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Monday, October 23. Needham has “Buy” rating and $90.0 target. As per Wednesday, June 14, the company rating was maintained by Morgan Stanley. The rating was maintained by KeyBanc Capital Markets with “Buy” on Wednesday, January 3. On Monday, November 13 the stock rating was upgraded by Dougherty to “Buy”. The firm has “Buy” rating by SunTrust given on Friday, February 10. The rating was maintained by Jefferies with “Hold” on Thursday, September 28.

Another recent and important Medidata Solutions, Inc. (NASDAQ:MDSO) news was published by Seekingalpha.com which published an article titled: “Medidata Solutions’ (MDSO) CEO Tarek Sherif on Q3 2017 Results – Earnings Call …” on October 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.